An observational study in Acute Kidney Injury, sponsored by Universität des Saarlandes. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-22.
Sponsored by Universität des Saarlandes · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 109 studies in Acute Kidney Injury with a site in Germany — 21 open to participants now, 24 under way, 1 of them phase 3. Acute Kidney Injury · Germany.
Among the 109 studies in Acute Kidney Injury with a site in Germany, this one is the 6th largest by planned enrollment of the 47 observational ones that give a count, is one of 9 that started in 2023, is one of 47 observational ones, reaches primary completion later than 9 of the 23 other live ones, and was the 88th registered.
1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.
Browse Acute Kidney Injury studies →21 of the 109 studies in Acute Kidney Injury with a site in Germany are open now. Recruiting first, the newest first:
University of Erlangen-Nürnberg Medical School · Sites in Germany
Ages 18+
Universität Münster · Sites in Germany
Ages 18+
AstraZeneca · Sites in Germany, United States, Argentina and 11 more countries
Ages 18–80
Fresenius Medical Care Deutschland GmbH · Sites in Germany, Czechia
Ages up to 18
Universitätsklinikum Hamburg-Eppendorf · Sites in Germany
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
109 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 11 · Phase 3 7 · Phase 4 4
First in 2002; this study’s year is marked. 9 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,000 is above the median of 160 across 814 observational studies indexed under Acute Kidney Injury.
Median enrollment 112 across the 62 interventional studies, 120 across the 47 observational. Of the 67 that completed or were terminated, 10 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 109 have an industry lead sponsor. The 10 most frequent:
Universität des Saarlandes is the lead sponsor of 68 studies on the registry; 17 are open to participants now.
Universität des Saarlandes has 1 study filed under Acute Kidney Injury — fewer than ten, so there is no comparison to draw.
9 of the studies in Acute Kidney Injury with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06615102Phase 3Universität MünsterReducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II | 2027-01 |
| NCT07579390Helsinki University Central HospitalEffects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE) | 2026-12 |
| NCT06180551Universität des SaarlandesHomburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis | 2026-12 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
| NCT06772025BayerA Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine | 2027-01-31 |
Add all 9 to your calendar (.ics) → With an account.
Among the 109 studies in Acute Kidney Injury with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Critically ill patients are at risk of developing a sudden decrease of kidney function which may be detected by a decrease in urine output or is diagnosed on the basis of blood tests for substances normally eliminated by the kidney, primarily creatinine.
Because it takes about 24 hours for the creatinine level to rise, even if both kidneys have ceased to function, better markers are needed.
This trial is investigating if the marker urinary dickkopf-3 (uDKK3) allows an early prediction of a sudden decrease of kidney function.
Urinary dickkopf-3 (uDKK3), a stress-induced renal tubular epithelium-derived glycoprotein, has been identified as a biomarker predicting persistent kidney dysfunction.
In this prospective observational trial in patients at high risk of developing acute kidney injury we will assess whether urinary dickkopf-3 serves as a predictor of acute kidney injury.
Patients of the intensive care units of Saarland University Hospital will be surveyed for up to two years after their admission to the intensive care unit.
The progression of the estimated Glomerular Filtration Rate and uDKK3 will be monitored.
Patients on intensive care units of the Saarland University Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
DKK-3-Urine measurement
Urinary dickkopf-3
Urinary dickkopf-3
Time frame: Throughout observational period, defined as timeframe from admission to intensive care unit up to two years after.
Estimated Glomerula Filtration Rate
Estimated Glomerula Filtration Rate by CKD-EPI-formula.
Time frame: Throughout observational period, defined as timeframe from admission to intensive care unit up to two years after.
Mortality
Number of patients who die during the observational period.
Time frame: Throughout observational period, defined as timeframe from admission to intensive care unit up to two years after.
End Stage Renal Disease
Number of patients with initiation of chronic kidney replacement therapy (maintenance dialysis or kidney transplantation).
Time frame: Throughout observational period, defined as timeframe from admission to intensive care unit up to two years after.
Length of renal replacement therapy
Length of time patients receive renal replacement therapy for chronic kidney injury.
Time frame: During the ICU stay.
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2023 (actual). Primary completion is estimated for Dec 2026, 36 months after the start.
Of 350 non-industry observational studies under Acute Kidney Injury, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 36 months is above that.
Counting every sponsor, half of 365 studies reached it within 24 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universität des Saarlandes